Patent details

EP2152709 Title: MORPHINAN COMPOUNDS

Basic Information

Publication number:
EP2152709
PCT Application Number:
PCT/US/2008/062089
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP087472387
PCT Publication Number:
WO/2008/137474
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MORPHINAN COMPOUNDS
French Title of Invention:
COMPOSÉS DE MORPHINANE
German Title of Invention:
MORPHINANVERBINDUNGEN
SPC Number:

Dates

Filing date:
30/04/2008
Grant date:
22/02/2012
EP Publication Date:
22/02/2012
PCT Publication Date:
13/11/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/02/2010
EP B1 Publication Date:
22/02/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
30/04/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/04/2008
 
 

Name:
Concert Pharmaceuticals Inc.
Address:
99 Hayden Avenue, Suite 100, Lexington, MA 02421, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
03/04/2012
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

Name:
TUNG Roger
Address:
United States (US)

Priority

1

Priority Number:
915130 P
Priority Date:
01/05/2007
Priority Country:
United States (US)

2

Priority Number:
916662 P
Priority Date:
08/05/2007
Priority Country:
United States (US)

3

Priority Number:
976044 P
Priority Date:
28/09/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 471/08;

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
19
Annual Fee Amount:
281 Euro
Expected Payer:
Last Annual Fee Payment Date:
25/04/2025
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56